Randomized trials of replacing saturated fatty acids with n-6 polyunsaturated fatty acids in coronary heart disease prevention: Not the gold standard?

Published on Jun 1, 2018in Prostaglandins Leukotrienes and Essential Fatty Acids2.864
· DOI :10.1016/j.plefa.2018.04.002
Jyrki K. Virtanen34
Estimated H-index: 34
(University of Eastern Finland)
Abstract Several trials in the 1950s through 1970s tested the hypothesis that replacing saturated fat in the diet predominantly with n-6 polyunsaturated fat (PUFA) would reduce the incidence of coronary heart disease (CHD), mainly through modifying blood lipid profile. Most of these trials did observe a reduction in serum total cholesterol in the intervention group, but many trials failed to find a significant reduction in the incidence of CHD. However, some meta-analyses have found a reduced incidence of CHD by pooling the results from the trials. Recently, new recovered and reanalyzed data has emerged from two of the old trials. The new findings seemed to counteract the classical diet-heart hypothesis, when they found no cardiovascular benefit and even suggested harm, despite reduction in the serum total cholesterol concentration after replacing saturated fat especially with n-6 PUFA. This has raised criticism regarding the validity of the dietary recommendations that suggest partially replacing saturated fats with n-6 PUFA. This paper introduces the classical diet-heart trials and their main results and how the new findings relate to the overall study data of the cardiovascular effects of the n-6 PUFA. For multiple reasons considered here, it is difficult to draw firm conclusions of the cardiovascular effects of the n-6 PUFA based only on the findings in the old diet-heart trials. A more comprehensive picture emerges when also other lines of evidence is considered. The overall study data, including findings also from prospective cohort studies and from dietary trials with intermediate outcomes, still suggests that replacing saturated fat with n-6 PUFA would rather be beneficial than harmful for the prevention of CHD.
  • References (47)
  • Citations (4)
📖 Papers frequently viewed together
12 Citations
160 Citations
20 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Jyrki K. Virtanen (University of Eastern Finland)H-Index: 34
#2Jason H.Y. Wu (UNSW: University of New South Wales)H-Index: 36
Last. Tomi-Pekka Tuomainen (University of Eastern Finland)H-Index: 28
view all 5 authors...
Background: The cardioprotective properties of linoleic acid (LA), a major n-6 (ω-6) polyunsaturated fatty acid (PUFA), have been recognized, but less is known about its associations with other causes of death. Relatively little is also known about how the minor n-6 PUFAs-γ-linolenic acid (GLA), dihomo-γ-linolenic acid (DGLA), and arachidonic acid (AA)-relate to mortality risk. Objective: We investigated the associations of serum n-6 PUFAs, an objective biomarker of exposure, with risk of death ...
7 CitationsSource
#1Shen Gao (Capital Medical University)H-Index: 4
#2Dong Zhao (Capital Medical University)H-Index: 35
Last. Jen-pei Liu (Capital Medical University)H-Index: 37
view all 7 authors...
Abstract Background Although basic research has suggested that oxidized low-density lipoprotein (ox-LDL) is involved in the pathogenesis of atherosclerosis, population observational studies have yielded conflicting results about the association between circulating ox-LDL and atherosclerotic cardiovascular disease (ASCVD). Therefore, we performed a systematic review and meta-analysis of currently available observational studies to verify the association between circulating ox-LDL and ASCVD. Metho...
11 CitationsSource
#1Jason H.Y. Wu (The George Institute for Global Health)H-Index: 36
#2Matti Marklund (Uppsala University)H-Index: 16
Last. Dariush Mozaffarian (Tufts University)H-Index: 122
view all 58 authors...
Summary Background The metabolic effects of omega-6 polyunsaturated fatty acids (PUFAs) remain contentious, and little evidence is available regarding their potential role in primary prevention of type 2 diabetes. We aimed to assess the associations of linoleic acid and arachidonic acid biomarkers with incident type 2 diabetes. Methods We did a pooled analysis of new, harmonised, individual-level analyses for the biomarkers linoleic acid and its metabolite arachidonic acid and incident type 2 di...
57 CitationsSource
Health effects of dietary fats have been extensively studied for decades. However, controversies exist on the effects of various types of fatty acids, especially saturated fatty acid (SFA), on cardiovascular disease (CVD). Current evidence supports that different types of dietary fatty acids have divergent effects on CVD risk, and the effects also depend strongly on the comparison or replacement macronutrient. A significant reduction in CVD risk can be achieved if SFAs are replaced by unsaturate...
30 CitationsSource
#1Frank M. SacksH-Index: 110
Last. Linda Van HornH-Index: 80
view all 12 authors...
Cardiovascular disease (CVD) is the leading global cause of death, accounting for 17.3 million deaths per year. Preventive treatment that reduces CVD by even a small percentage can substantially re...
219 CitationsSource
#1Graciela Delgado (Heidelberg University)H-Index: 23
#2Winfried März (University of Graz)H-Index: 94
Last. Marcus E. Kleber (FSU: University of Jena)H-Index: 54
view all 5 authors...
Background Omega-6 polyunsaturated fatty acids (omega-6 PUFA) are recommended in European cardiovascular prevention guidelines. However, individual fatty acids have distinct biological functions, and there have been conflicting reports about the association of omega-6 PUFA with cardiovascular risk. Objective The aim of our study was to investigate the association of individual omega-6 fatty acids with mortality in a cohort of patients referred for coronary angiography. Methods Omega-6 PUFA propo...
11 CitationsSource
#1Steven Hamley (Deakin University)H-Index: 6
A cornerstone of conventional dietary advice is the recommendation to replace saturated fatty acids (SFA) with mostly n-6 polyunsaturated fatty acids (PUFA) to reduce the risk of coronary heart disease (CHD). Many clinical trials aimed to test this advice and have had their results pooled in several meta-analyses. However, earlier meta-analyses did not sufficiently account for major confounding variables that were present in some of those trials. Therefore, the aim of the study was to account fo...
28 CitationsSource
#1Zoë Harcombe (University of the West of Scotland)H-Index: 7
#2Julien S. Baker (University of the West of Scotland)H-Index: 33
Last. Bruce Davies (UNSW: University of New South Wales)H-Index: 31
view all 5 authors...
Objectives National dietary guidelines were introduced in 1977 and 1983, by the USA and UK governments, respectively, with the ambition of reducing coronary heart disease (CHD) mortality by reducing dietary fat intake. A recent systematic review and meta-analysis by the present authors, examining the randomised controlled trial (RCT) evidence available to the dietary committees during those time periods, found no support for the recommendations to restrict dietary fat. The present investigation ...
21 CitationsSource
#1Liana C. Del Gobbo (Stanford University)H-Index: 14
#2Fumiaki Imamura (Medical Research Council)H-Index: 31
Last. Dariush Mozaffarian (Tufts University)H-Index: 122
view all 49 authors...
IMPORTANCE The role of omega-3 polyunsaturated fatty acids for primary prevention of coronary heart disease (CHD) remains controversial. Most prior longitudinal studies evaluated self-reported cons ...
126 CitationsSource
#1Fumiaki Imamura (University of Cambridge)H-Index: 31
#2Renata Micha (Tufts University)H-Index: 43
Last. Dariush Mozaffarian (Tufts University)H-Index: 122
view all 7 authors...
Background Effects of major dietary macronutrients on glucose-insulin homeostasis remain controversial and may vary by the clinical measures examined. We aimed to assess how saturated fat (SFA), monounsaturated fat (MUFA), polyunsaturated fat (PUFA), and carbohydrate affect key metrics of glucose-insulin homeostasis. Methods and Findings We systematically searched multiple databases (PubMed, EMBASE, OVID, BIOSIS, Web-of-Knowledge, CAB, CINAHL, Cochrane Library, SIGLE, Faculty1000) for randomised...
84 CitationsSource
Cited By4
#1Nirajan Shrestha (Griffith University)H-Index: 4
#2Simone L. Sleep (Griffith University)H-Index: 2
Last. Deanne H. Hryciw (Griffith University)H-Index: 24
view all 8 authors...
Maternal nutrition plays a critical role in fetal development and can influence adult onset of disease. Linoleic acid (LA) and alpha- linolenic acid (ALA) are major omega-6 (n-6) and n-3 polyunsaturated fatty acids (PUFA), respectively, that are essential in our diet. LA and ALA are critical for the development of the fetal neurological and immune systems. However, in recent years, the consumption of n-6 PUFA has increased gradually worldwide, and elevated n-6 PUFA consumption may be harmful to ...
2 CitationsSource
#1Oscar Coltell (James I University)H-Index: 17
#2José V. Sorlí (ISCIII: Carlos III Health Institute)H-Index: 31
view all 13 authors...
Many early studies presented beneficial effects of polyunsaturated fatty acids (PUFA) on cardiovascular risk factors and disease. However, results from recent meta-analyses indicate that this effect would be very low or nil. One of the factors that may contribute to the inconsistency of the results is that, in most studies, genetic factors have not been taken into consideration. It is known that fatty acid desaturase (FADS) gene cluster in chromosome 11 is a very important determinant of plasma ...
#1Johanna-Katharina Schönbach (University of Bremen)
#2Wilma J. Nusselder (Erasmus University Medical Center)H-Index: 36
Last. Stefan K. Lhachimi (University of Bremen)H-Index: 16
view all 3 authors...
There is evidence that replacing saturated fat (SFA) with polyunsaturated fat (PUFA) lowers ischemic heart disease (IHD). In order to improve the population’s diet, the World Health Organization has called for the taxation of foods that are high in SFA. We aimed to assess the potential health gains of a European fat tax by applying the SFA intake reduction that has been observed under the Danish fat tax to six other European countries. For each country, we created a fat tax scenario with a decre...
Acute coronary syndrome (ACS) refers to ischemic conditions that occur as a result of atherosclerotic plaque rupture and thrombus formation. It has been shown that lipid peroxidation may cause plaque instability by inducing inflammation, apoptosis, and neovascularization. There is some evidence showing that these oxidized lipids may have a prognostic value in ACS. For instance, higher levels of oxidized phospholipids on apo B-100 lipoproteins (OxPL/apoB) predicted cardiovascular events independe...
1 CitationsSource
#1Gregory C. Shearer (PSU: Pennsylvania State University)H-Index: 19
#2Rachel E. Walker (PSU: Pennsylvania State University)H-Index: 5
Abstract Oxylipins are lipid mediators produced from polyunsaturated fatty acid (PUFA) metabolism, and are thought to be a molecular explanation for the diverse biological effects of PUFAs. Like PUFAs, oxylipins are distinguished by their omega-6 (n6) or omega-3 (n3) chemistry. We review the use of n6 oxylipins as biomarkers of disease and their use in diagnosis and risk assessment. We show cases where oxylipins derived from linoleate (LA) or arachidonate (AA) produced by the activities of lipox...
7 CitationsSource
Abstract Epidemiologists have been studying the effect of n-6 polyunsaturated fatty acids (PUFAs) intake on the risk of cardiovascular disease (CVD) for many decades. Abundant evidence from prospective studies on the clinical endpoints of CVD, including cohort studies measuring n-6 PUFA intake by food frequency questionnaires and nested case-control studies using biomarkers of intake level, strongly support that higher intakes of n-6 PUFAs are associated with a lower risk of CVD. Furthermore, a ...
5 CitationsSource